On December 16, 2024, Fluid Biomed announced the close of its $27-million Series A funding round co-led by Amplitude Ventures and an undisclosed investor, with follow-up investment from LifeArc Ventures. Fluid Biomed plans to use the funds to fuel the development of its innovative stent for brain aneurysms.
Amplitude Ventures, based in Canada, is a full-stack venture capital firm using a unique growth model to build breakout companies based on groundbreaking technology and with world-class management teams.
LifeArc Ventures, based in the United Kingdom, invests in early-stage science-led companies that can benefit from their advice, scientific insight and venture funding.
Osler, Hoskin & Harcourt LLP advised Amplitude Ventures and LifeArc Ventures with a team consisting of Michael Grantmyre and Patrick Musgrave (Emerging and High Growth Companies).
Key Contact
Partner, Emerging and High Growth Companies, Calgary
Team
Associate, Emerging and High Growth Companies, Calgary
